tiprankstipranks

1315 Capital II, L.P. Insider Profile

4 Followers
1315 Capital II, L.P., Ten Percent Owner at Interpace Diagnostics Group, holds 9.41M shares in Interpace Diagnostics Group (Ticker: IDXG). Most recently, 1315 Capital II, L.P. Bought 9,405,941 shares of Interpace Diagnostics Group on Feb 17, 2026 for an estimated value of $19.00M.
tipranks
1315 Capital II, L.P.

1315 Capital II, L.P.
Interpace Diagnostics Group (IDXG)
Ten Percent Owner

Not Ranked
1315 Capital II, L.P. has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$17M
100.00%
A breakdown of 1315 Capital II, L.P.'s holdings

Insider Roles

Interpace Diagnostics Group
(IDXG)
Ten Percent Owner
Roles that 1315 Capital II, L.P. holds in companies

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by 1315 Capital II, L.P.

1315 Capital II, L.P.'s Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Interpace Diagnostics Group
Feb 17, 2026
Ten Percent Owner
Informative Buy
19.00M
$16.70M
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Feb 17, 2026
Informative Buy
$19.00M
9,405,941
$2.02
List of latest transactions for each holding click on a transaction to see 1315 Capital II, L.P.'s performance on stock

1315 Capital II, L.P. insider profile FAQ

What is the percentage of profitable transactions made by 1315 Capital II, L.P.?
The percentage of profitable transactions made by 1315 Capital II, L.P. is ―.
    What is the average return per transaction made by 1315 Capital II, L.P.?
    The average return per transaction made by 1315 Capital II, L.P. is ―.
      What stocks does 1315 Capital II, L.P. hold?
      1315 Capital II, L.P. holds: IDXG stocks.
        What was 1315 Capital II, L.P.’s latest transaction?
        1315 Capital II, L.P. latest transaction was an Informative Buy of $19.00M.
          What was 1315 Capital II, L.P.'s most profitable transaction?
          1315 Capital II, L.P.’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is 1315 Capital II, L.P.'s role in Interpace Diagnostics Group?
            1315 Capital II, L.P.'s role in Interpace Diagnostics Group is Ten Percent Owner.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.